--- title: "Noro202 Study - Reviews, Revenue and Downloads in Brazil | Apple App Store" description: "Welcome to the Noro202 Study: The purpose of this study is to assess the immune response of the Bivalent GI.1/GII.4 vaccine against Norovirus in healthy adults, as well as how safe the vaccine is. " --- # Noro202 Study — Brazil ![Noro202 Study App Icon](https://is1-ssl.mzstatic.com/image/thumb/Purple116/v4/c4/05/2f/c4052fa5-4edd-43aa-2f32-05d5b0eefff9/AppIcon-0-0-1x_U007emarketing-0-0-0-10-0-0-sRGB-0-0-0-GLES2_U002c0-512MB-85-220-0-0.png/434x0w.png) **Developer:** [OBVIO HEALTH USA](https://apptail.io/developer/obvio-health-usa-Hlkc) **Category:** Medical **Rating:** N/A (0 ratings) **Price:** Free **Bundle ID:** com.obvio.claimit.vaxart **Store:** Apple App Store **Country:** Brazil **Version:** 1.0 (released 2023-03-15) **Original Release:** 2023-03-15 **Languages:** English **App Store Link:** [Download on Apple App Store](https://apps.apple.com/br/app/app/id1666235380) **AppTail Page:** [https://apptail.io/app/noro202-study-HaMl/brazil](https://apptail.io/app/noro202-study-HaMl/brazil) ## Noro202 Study Description Welcome to the Noro202 Study: The purpose of this study is to assess the immune response of the Bivalent GI.1/GII.4 vaccine against Norovirus in healthy adults, as well as how safe the vaccine is. New (investigational) medications, drugs and devices must be approved for use by the United States Food and Drug Administration (FDA). The Bivalent GI.1/GII.4 vaccine is an experimental vaccine. This means that it is not an approved vaccine to prevent healthy adults from acquiring Norovirus in the United States or in any other country. This research is being sponsored and conducted by Vaxart Inc. Subject Journey A subject who is identified as eligible for this study during screening will be invited to download the Noro202 Study App via e-mail. Upon download, the participants create an account and is contacted by a study team member to complete the Informed Consent process. A series of screens explains the parameters of the study, including: o Privacy Policy o Data Gathering & Usage o Study Tasks & Surveys o Time Commitment o Option to Withdraw Subjects will connect with a member of the study team to ask questions and obtain a comprehensive understanding of the study prior to signing the informed consent form. Intervention Period: Daily Tasks Subjects will contribute data to the study by completing questionnaires and data uploads over a baseline period and 8 day active trial period. Subjects can interact with the study team via secure chat as needed. ## Noro202 Study Screenshots - [Screenshot 1](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource113/v4/0d/3a/d2/0d3ad2c8-5e87-3ffb-f0d6-d87daf20e20f/8db88521-4361-4b70-bf6b-ff59a379ff11_1.png/1242x2688.png) - [Screenshot 2](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource123/v4/0f/b9/4c/0fb94cf7-8e2e-4a36-39ea-226826c34d34/4ffc6fa3-7906-4cb6-8ce3-48da46c51f0c_2.png/1242x2688.png) - [Screenshot 3](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource113/v4/e3/10/f3/e310f325-e82d-9c39-00e6-c679a32769bd/089f0989-8bb4-4d08-a9f3-15f89e65107a_3.png/1242x2688.png) - [Screenshot 4](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource113/v4/17/c8/88/17c88828-05fa-25f9-7074-4d92e087368c/e4151fd0-68d0-4cc1-a943-57681ed811de_4.png/1242x2688.png) ## Noro202 Study Available In - [Brazil](https://apptail.io/app/noro202-study-HaMl/brazil) - [Canada](https://apptail.io/app/noro202-study-HaMl/canada) - [Chile](https://apptail.io/app/noro202-study-HaMl/chile) - [China](https://apptail.io/app/noro202-study-HaMl/china) - [Germany](https://apptail.io/app/noro202-study-HaMl/germany) - [Algeria](https://apptail.io/app/noro202-study-HaMl/algeria) - [Egypt](https://apptail.io/app/noro202-study-HaMl/egypt) - [Spain](https://apptail.io/app/noro202-study-HaMl/spain) - [France](https://apptail.io/app/noro202-study-HaMl/france) - [United Kingdom](https://apptail.io/app/noro202-study-HaMl/united-kingdom) - [Croatia](https://apptail.io/app/noro202-study-HaMl/croatia) - [Kuwait](https://apptail.io/app/noro202-study-HaMl/kuwait) - [Malaysia](https://apptail.io/app/noro202-study-HaMl/malaysia) - [Saudi Arabia](https://apptail.io/app/noro202-study-HaMl/saudi-arabia) - [Singapore](https://apptail.io/app/noro202-study-HaMl/singapore) - [Türkiye](https://apptail.io/app/noro202-study-HaMl/turkey) - [United States](https://apptail.io/app/noro202-study-HaMl/united-states) - [South Africa](https://apptail.io/app/noro202-study-HaMl/south-africa) --- ## About AppTail [AppTail](https://apptail.io) is a mobile app intelligence platform providing app analytics, ASO (App Store Optimization) tools, keyword tracking, competitor analysis, revenue estimates, and review monitoring for iOS App Store apps. Track your app's performance, discover ranking keywords, monitor competitors, and analyze market trends. - [Search Apps](https://apptail.io) - [Top Charts](https://apptail.io/top-iphone-apps) - [Sign Up for Full Access](https://app.apptail.io/signup?utm_campaign=ai-crawl&utm_content=footer) *Data provided by [AppTail](https://apptail.io) - Mobile App Intelligence Platform*